Clls stock forecast

7 days ago · Analysts forecast that Cellectis SA (NASDAQ:CLLS) will post earnings of ($0.72) per share for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Cellectis’ earnings. Cellectis posted earnings per share of ($0.36) during the same quarter last year, which indicates a negative year-over-year growth rate of 100%.

The recent decline in stock price could raise concerns from investors as the firm closed today at a share price of 14.1 on 295,690 in volume. The company directors and management have failed to build on market volatilities in February.However, diversifying your overall positions with Cellectis S A may protect your principal portfolio during upcoming market swings. Citigroup Raises Cellectis (NASDAQ:CLLS) Price Target to ... Cellectis (NASDAQ:CLLS) had its target price increased by Citigroup from $14.00 to $16.00 in a research report report published on Friday, The Fly reports. The brokerage currently has a neutral Clean Energy Fuels Corp, CLNE:NSQ forecasts - FT.com All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Cellectis Earnings - Investing.com

Find the latest Earnings Report Date for Cellectis S.A. American Depositary Shares (CLLS) at Nasdaq.com. Cellectis - CLLS - Stock Price & News | The Motley Fool Real time Cellectis (CLLS) stock price quote, stock graph, news & analysis. Real time Cellectis (CLLS) stock price quote, stock graph, news & analysis. The Ascent is The Motley Fool's new Cellectis S.A. (CLLS) Stock Analysis & News | Seeking Alpha Get breaking news and analysis on Cellectis S.A. (CLLS) stock, price quote and chart, trading and investing tools. CLLS | Cellectis S.A. ADR Advanced Charts | MarketWatch

Cellectis S.A Stock Forecast, "CLLS" Stock Predictons by ...

Brokerages Anticipate Cellectis SA (NASDAQ:CLLS) to ... 7 days ago · Analysts forecast that Cellectis SA (NASDAQ:CLLS) will post earnings of ($0.72) per share for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Cellectis’ earnings. Cellectis posted earnings per share of ($0.36) during the same quarter last year, which indicates a negative year-over-year growth rate of 100%.

Cellectis S.A. ADR, CLLS Quick Chart - (NAS) CLLS ...

Stock Reversals is stock advisory and market forecasting service. From swing trading strategies and 3x ETF advice to sector analysis our subscription service provides info about individual trades, market corrections or trends. Cellectis SA - NASDAQ:CLLS - Stock Quote & News - TheStreet Mar 13, 2020 · View detailed financial information, real-time news, videos, quotes and analysis on Cellectis SA (NASDAQ:CLLS). Explore commentary on Cellectis SA … MU: Micron Technology Inc - Stock Price, Quote and News - CNBC Get Micron Technology Inc (MU:NASDAQ) real-time stock quotes, news and financial information from CNBC. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Oct 05, 2019 · The stock traded up 0.34% over the course of the day. Itamar Medical (OTC: ITMMF) stock hit $0.14 on Friday morning, setting a new 52-week low. …

CLLS Stock Summary. With a year-over-year growth in debt of 2,216.27%, Cellectis SA's debt growth rate surpasses 98.43% of about US stocks. In terms of twelve month growth in earnings before interest and taxes, Cellectis SA is reporting a growth rate of 404.86%; that's higher than 96.71% of US stocks.

Cellectis - CLLS - Stock Price & News | The Motley Fool Real time Cellectis (CLLS) stock price quote, stock graph, news & analysis. Real time Cellectis (CLLS) stock price quote, stock graph, news & analysis. The Ascent is The Motley Fool's new